Area of research
Oncology · Genetics
Research interest
Research interests include Cancer Cells and Metastasis, Cancer Immunotherapy and Biomarkers, Mesenchymal stem cell research, and Extracellular vesicles in disease.
Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K/AKT pathway
Spatial relationships and interactions of immune cell niches are linked to the pathologic response of muscle-invasive bladder cancer to neoadjuvant therapy
Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis
FAP+ gastric cancer mesenchymal stromal cells via paracrining INHBA and remodeling ECM promote tumor progression
Gastric Cancer Mesenchymal Stem Cells Trigger Endothelial Cell Functional Changes to Promote Cancer Progression
Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells
<b>Experts' </b><b>C</b><b>ognition-Driven Ensemble Deep Learning </b><b>f</b><b>or External Validation of Predicting Pathological Complete Response to Neoadjuvant Chemotherapy </b><b>f</b><b>rom Histological Images in Breast Cancer</b>
Bnip3 promotes the release of mitochondria-derived extracellular vesicles in cardiac fibroblasts to exacerbate inflammation response after myocardial infarction
Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression
Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer
Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation
Combining the tumor-stroma ratio with tumor-infiltrating lymphocytes improves the prediction of pathological complete response in breast cancer patients
hsa_circ_0005991 promotes epithelial-mesenchymal transition by regulating miR-30b-3p/Cdc42EP1 axis in ovary endometriosis
Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells
Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression
Gastric cancer-derived exosomes induce PD-L1 expression on human bone marrow mesenchymal stem cells through the AKT-c-Myc signal axis
Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review)
G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2
Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth
Gastric cancer mesenchymal stem cells inhibitnatural killer cell function by up-regulating FBP1
Identification of Gingivitis-Related Genes Across Human Tissues Based on the Summary Mendelian Randomization
Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis
Bone Marrow Mesenchymal Stem Cell-Derived Hepatocyte-Like Cell Exosomes Reduce Hepatic Ischemia/Reperfusion Injury by Enhancing Autophagy
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to-Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects
Ovarian Sclerosing Stromal Tumor and Müllerian Cyst in an 11-yr-old Girl: A Case Report and Review of the Literature
Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7
Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4 <sup>+</sup> T Cell
Platelets enhance the ability of bone-marrow mesenchymal stem cells to promote cancer metastasis